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United States, 2 Department of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International
University, Miami, FL, United States
The blood–brain barrier (BBB) selectively regulates the cellular exchange of
macromolecules between the circulation and the central nervous system (CNS). Here,
we hypothesize that Zika virus (ZIKV) infects the brain via a disrupted BBB and
altered expression of tight junction (TJ) proteins, which are structural components
of the BBB. To assess this hypothesis, in vitro and in vivo studies were performed
using three different strains of ZIKV: Honduras (ZIKV-H), Puerto Rico (ZIKV-PR), and
Uganda (ZIKV-U). Primary human brain microvascular endothelial cells (BMECs) were
productively infected by all studied ZIKV strains at MOI 0.01, and were analyzed by
plaque assay, immunofluorescence for NS1 protein, and qRT-PCR at 2 and 6 days
post-infection (dpi). Compared to mock-infected controls, expression level of ZO-1
was significantly upregulated in ZIKV-H-infected BMECs, while occludin and claudin-
5 levels were significantly downregulated in BMECs infected by all three studied
viral strains. Interestingly, BMEC permeability was not disturbed by ZIKV infection,
even in the presence of a very high viral load (MOI 10). All studied ZIKV strains
productively infected wild-type C57BL/J mice after intravenous infection with 107 PFU.
Viral load was detected in the plasma, spleen, and brain from 1 to 8 dpi. Peak brain
infection was observed at 2 dpi; therefore, TJ protein expression was assessed at
this time point. Claudin-5 was significantly downregulated in ZIKV-U-infected animals
and the BBB integrity was significantly disturbed in ZIKV-H-infected animals. Our
results suggest that ZIKV penetrates the brain parenchyma early after infection with
concurrent alterations of TJ protein expression and disruption of the BBB permeability
in a strain-dependent manner.
Keywords: Zika virus, blood–brain barrier, endothelial cells, tight junctions, neuroinfection
INTRODUCTION
Neurotropic viral infection can directly and indirectly (e.g., by inducing local immune responses)
disrupt the complex structural and functional architecture of the central nervous system (CNS).
In addition, several neurological disorders are often associated with autoimmune mechanisms
initiated by a viral infection, such as Guillain-Barré syndrome (van den Berg et al., 2014).
Neurotropic viruses invade the CNS by various routes, including retrograde axonal transport from
infected motor and olfactory neurons, infected immune cells that cross the brain endothelium, or
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by direct infection of cells at the blood–brain barrier
(BBB), blood-cerebrospinal fluid barrier, and the meningeal-
cerebrospinal fluid barrier (Ludlow et al., 2016). BBB dysfunction
appears to be the main route for viral neuroinvasion, and it is
preceded by changes in the expression of cytokines, chemokines,
cell adhesion molecules (Kim, 2008), and disruption of tight
junction (TJ) integrity, as observed in human immunodeficiency
virus (HIV) (Pu et al., 2005; Toborek et al., 2005; Strazza et al.,
2011; McRae, 2016; Bertrand et al., 2019a), hepatitis C virus
(HCV) (Liu et al., 2009; Crema et al., 2015), and West Nile virus
(WNV) (Neal, 2014; Suen et al., 2014) infections. Part of this
effect is related to high susceptibility of vascular endothelial
cells to oxidative and proinflammatory insult (Toborek et al.,
1995; Lee et al., 2004), combined with efficient intercellular
communication (Cho et al., 2017). HCV and WNV, together
with several other major human pathogens, including Japanese
encephalitis virus, dengue virus, and Zika virus (ZIKV), are
members of the Flaviviridae family of viruses. These viruses
have significant neuroinvasive characteristics and are regarded as
neurotropic (Neal, 2014).
Zika virus is an enveloped, mosquito-borne flavivirus,
containing a single-stranded positive-sense RNA genome (Yun
and Lee, 2017). Two main lineages, named African and Asian,
have been identified so far from the entire genome sequencing
data. The African lineage is composed of clusters from Uganda
and Nigeria, and the majority of strains were isolated from
enzootic vectors, whereas the Asian lineage has been associated
with the majority of the human epidemics (Weaver et al., 2016).
Compared to other flavivirus, ZIKV is less neuroinvasive, rarely
causing meningitis and encephalitis (Carteaux et al., 2016). ZIKV
can infect a variety of cells, including neural progenitor cells,
causing microcephaly and neurodevelopmental injuries (Tang
et al., 2016). Human and animal model studies have observed
ZIKV virions and ZIKV nucleic acid in the semen, saliva, tears,
urine, eyes, brain, testes, and female genital tract (Miner and
Diamond, 2017). ZIKV infects endothelial cells derived from the
aorta, brain, and lymphatic and umbilical vessels (Liu et al., 2009,
2016; Richard et al., 2017). In brain microvascular endothelial
cells (BMEC), ZIKV infection persists, despite innate antiviral
responses, functioning as a viral reservoir capable of spreading
the infection into neuronal compartments (Retallack et al., 2016).
In recent years, ZIKV has been recognized as the cause of
severe neurological disorders, such as Guillain-Barre syndrome
in adults (Oehler et al., 2014; Cao-Lormeau et al., 2016; Watrin
et al., 2016) and microcephaly in infants (Brasil et al., 2016a,b;
Schuler-Faccini et al., 2016). Unlike other flavivirus, ZIKV can
be transmitted via sexual contact (Foy et al., 2011; Musso et al.,
2015; Davidson et al., 2016) and possibly by transfusion of
whole blood and/or blood products (Barjas-Castro et al., 2016;
Motta et al., 2016). Therefore, ZIKV stands as an emerging
virus with multiple routes of transmission, capable of crossing
the BBB independently of the route of infection. Here, we
aimed to characterize the role of the BBB in the onset of ZIKV
infection of the CNS, and to characterize possible differences
in neurovirulence according to viral strains from the African
and Asian lineages, using both in vivo and in vitro models
of ZIKV-infection.
MATERIALS AND METHODS
Cell Culture
C6/36 cells (Aedes albopictus clone, mosquito cells) and Vero
cells (African green monkey kidney epithelial cells) were obtained
from the American Type Culture Collection (ATCC). C6/36
cells (ATCC, CRL-1660) were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) containing GlutaMAX (Thermo Fisher
Scientific) and supplemented with 10% fetal bovine serum
(FBS) (Thermo Fisher Scientific) at 28◦C with 5% CO2. Vero
cells (ATCC CCL-81) were cultured in DMEM containing
GlutaMAX (Thermo Fisher Scientific) and supplemented with
10% heat-inactivated fetal bovine serum (FBS) (Thermo Fisher
Scientific) at 37◦C with 5% CO2. Primary human BMECs
(Cell Systems, ACBRI 376) were cultured in pre-coated plates
with Attachment Factor (Cell Systems) and with Cell Systems
Medium, pre-formulated with 10% serum and supplemented
with CultureBoost containing animal derived growth factors
(Cell Systems), at 37◦C with 5% CO2.
Virus Propagation and Tittering
Zika virus strains R103451 (ATCC VR-1848, Honduras 2015,
ZIKV-H), PRVABC9 (ATCC VR-1843, Puerto Rico 2015, ZIKV-
PR), and MR 766 (ATCC VR-1838, Uganda 1947, ZIKV-U)
were obtained from ATCC and propagated in C3/36 mosquito
cells at a multiplicity of infection (MOI) of 0.01. Supernatants
were collected three to four days post-infection (dpi), clarified
by centrifugation at 1,000 × g for 5 min, and concentrated
using centrifugal filters with 30 kDa molecular weight cut-off
(EMDMilipore). Virus was tittered by plaque assay using Vero
cells with a 0.7% agarose overlay. Foci of plaques were detected
at 3 dpi, following fixation with 10% paraformaldehyde solution
and staining with 1% crystal violet.
Mouse Infection
All animal procedures were approved by the University of Miami
Institutional Care and Use Committee (IACUC) in accordance
with the National Institutes of Health (NIH) guidelines. Male
and female C57BL/6J mice (aged 10–12 weeks) were purchased
from Jackson Laboratory and randomly assigned to various ZIKV
infection groups. Mice were anesthetized intraperitoneally with
a mixture of ketamine (100 mg/kg body weight) and xylazine
(5 mg/kg body weight), then injected intravenously via retro-
orbital venous sinus with 100 µL of 107 plaques forming units
(PFU) of ZIKV-H, ZIKV-PR, ZIKV-U, or vehicle (PBS; mock-
infection). After animals were euthanized, whole blood was
collected via cardiac puncture, followed by perfusion with normal
saline. Brain and spleen tissue were harvested, snap frozen in
liquid nitrogen, and stored at –80◦C. Whole blood samples were
centrifuged at 1,000 × g for 10 min to obtain plasma and stored
at –80◦C.
Assessment of ZIKV Infection
Total RNA was isolated from 200 µL of plasma or cell culture
supernatant using MinElute Virus Spin kit (Qiagen). Total RNA
was also isolated from 400 µL of tissue homogenates (spleen
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and half brain) or 100 µL of cell culture lysates, using RNeasy
tissue kit (Qiagen). RT-qPCR of plasma and tissue total RNA
samples was performed using primers specific for all ZIKV strains
evaluated in the present study (5′-CCG CTG CCC AAC ACA
AG-3′ and 5′-CCA CTA ACG TTC TTT TGC AGA CAT-
3′), probe (5′-6FAM-AGC CTA CCT TGA CAA GCA GTC
AGA CAC TCA A-IABkFQ-3′) (Integrated DNA Technologies),
and the qScript XLT 1-Step RT-qPCR ToughMix (Quantabio)
reaction mix in a 7500 Real-Time PCR System (Thermo Fisher
Scientific). RNA absolute quantification per cell was achieved by
fitting to serially diluted standard curves of plasmids containing
the target region of ZIKV (108 to 101 viral copies) and the mouse
housekeeping gene hemoglobin beta chain complex (HBB) (108
to 101 gene copies), as previously described by our group
(Bertrand et al., 2019b). Viral copy numbers less than 101 were
considered undetectable and were plotted as zero in the graphs.
Brain Microvessel Isolation
Mouse brain microvessels were isolated as previously described
(Park et al., 2013; Andras et al., 2017). Briefly, brains were
homogenized in cold isolation buffer (102 mM NaCl, 4.7 mM
KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4,
15 mM HEPES, 25 mM NaHCO3, 10 mM glucose, 1 mM Na
pyruvate) with freshly added protease inhibitors (Thermo Fisher
Scientific) and filtered through a 300 µm nitrocellulose mesh
filter (EMDMilipore). Then, 26% dextran (MW, 150 kDa) in
isolation buffer was added to the filtered brain homogenate,
mixed, and centrifuged at 5,800 × g for 20 min at 4◦C.
The supernatant was removed, pellets were resuspended in
isolation buffer, and filtered through a 120 µm nitrocellulose
mesh filter (EMDMilipore). Filtered homogenates were then
re-pelleted by centrifugation (1,500 × g, 10 min, 4◦C) and
re-resuspended either in 200 µL of radioimmunoprecipitation
assay (RIPA) buffer (Thermo Fisher Scientific) supplemented
with protease inhibitors for immunoblotting, or in PBS
for RNA sequencing.
Immunoblotting and Immunostaining
Protein fractions from cell culture lysates and isolated brain
microvessels were extracted with RIPA buffer supplemented
with protease inhibitors and 1% Triton X-100 to inactivate
ZIKV. Protein concentrations were measured by Pierce
BCA Protein Assay Kit (Thermo Fisher Scientific). The
proteins (20 µg/well) were loaded on sodium dodecyl
sulfate (SDS) polyacrylamide 4–20% ready gels (BioRad)
and electrotransferred to a nitrocellulose membrane using a
transfer pack system (BioRad). The blots were probed overnight
at 4◦C with the following primary antibodies: rabbit anti-ZIKV
NS-1 (GeneTex; #GTX133307), rabbit anti-Claudin-5 (Abcam;
#ab15106), rabbit anti-ZO-1 (Abcam; #ab96587), and rabbit
anti-Occludin (Abcam; #ab167161) (1:1,000) in 5% BSA in
TBS-T, overnight at 4◦C. Then, the samples were incubated with
conjugated secondary anti-rabbit antibody (Licor) (1:20,000)
in 5% BSA in TBS-T, for 1 h at room temperature. The
blots were washed three times in TBS-T for 5 min after each
incubation step. Membranes were imaged in the Licor CLX
imaging system and signal quantification was performed using
ImageStudio 4.0 software. The GAPDH housekeeping gene was
used as a reference.
Immunostaining was performed on primary human BMECs
cultured on 8-well chamber slides (Thermo Fisher Scientific).
Upon 80% confluency, cells were infected with different
strains of ZIKV (ZIKV-H, ZIKV-PR, ZIKV-U, or mock-
infected controls) at MOI 0.01 for 48 h. After the incubation
period, cells were carefully washed twice with PBS and fixed
with 4% paraformaldehyde solution. Fixed cell monolayers
were permeabilized with 0.1% Triton-X solution in PBS,
followed by blocking with 4% bovine serum albumin (BSA)
in PBS for 1 h at room temperature. Chamber slides
were incubated overnight at 4◦C with rabbit antibodies
against the ZIKV NS-1 protein (GeneTex; #GTX133307)
(diluted 1:100 in 4% BSA in PBS). Anti-rabbit Alexa-594
secondary antibody (diluted 1:500 in 1% BSA in PBS)
(Thermo Fisher Scientific) and Hoechst (diluted 1:2,000 in
PBS) (Thermo Fisher Scientific) were used for detection of
ZIKV NS-1 protein and cell nuclei, respectively. Imaging
was performed on an Olympus FluoView 1200 confocal
microscope with a 60× oil immersion lens and analyzed using
ImageJ software.
In vitro and in vivo Permeability Assays
In vitro endothelial permeability assays were performed in 6-
well 0.4 µm pore transwell plates (Corning). Primary human
BMECs were seeded at 2 × 105 cells per insert in appropriate
media, which was changed every 48 h, and transendothelial
electrical resistance (TEER) measurements were acquired daily
(data not shown). Five days after seeding, cells were inoculated
with different strains of ZIKV at MOI 10, diluted in the
appropriate media, in quadruplicates. At 2 dpi, media was
replaced with Hanks balanced salt solution in both chambers,
and fluorescently tagged dextran (FITC-Dextran, Sigma-Aldrich)
of 10 kDa or 20 kDa was added to the upper chamber
at a final concentration of 0.5 mg/mL. Fluorescent marker
translocation was analyzed after 90 min of incubation by
transferring 100 µL aliquots from the lower chamber to
a 96-well plate and reading fluorescence at 485 nm (Ex)
and 525 nm (Em).
In vivo BBB permeability assays were performed using sodium
fluorescein (NaF) as described before (Zhong et al., 2012; Park
et al., 2013, 2016). Briefly, 20 min before euthanasia mice
were injected intraperitoneally with 100 µL of 10% sodium
fluorescein. Blood was collected via heart puncture, and the
mice were transcardially perfused with saline to remove blood
from the intravascular compartment. Brains were harvested
and thoroughly homogenized in PBS, containing freshly added
protease inhibitors, and cleared of debris by centrifugation
(1,250 × g, 5 min, at 4◦C). Proteins were precipitated with
100% trichloroacetic acid (TCA; Sigma-Aldrich) overnight at
4◦C. After the incubation period, samples were centrifuged at
10,000 × g, 15 min, at 4◦C and supernatants were harvested and
mixed with 0.05 M sodium tetraborate buffer. A NaF standard
curve was prepared by serially diluting 0.01% NaF in saline at
a 1:2 ratio, and a total of 12 NaF concentrations were used.
NaF fluorescence was measured in a fluorescent plate reader (Ex:
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485 nm; Em: 525 nm). Protein levels were measured by the Pierce
BCA Protein Assay Kit for normalization of NaF fluorescence.
Mouse Brain Microvessel Transcriptome
A total of 32 animals were infected with different strains of ZIKV
(ZIKV-H, ZIKV-PR, ZIKV-U) or vehicle to characterize the
impact of infection on transcriptome of brain microvessels. Each
group was composed of 8 animals, 4 males and 4 females. Animals
were sacrificed at 2 dpi and whole brain tissue was submitted
for microvessel isolation, as described above and elsewhere (Park
et al., 2013). Total RNA was isolated using the iPrep PureLink
Total RNA kit (Thermo Fisher Scientific). RNA quantitation and
quality analyses were performed using Qubit RNA HS Assay
kit (Thermo Fisher Scientific) and Agilent RNA 6000 Pico kit
(Agilent Technologies). RNA-Seq libraries were prepared using
the TruSeq mRNA Library Prep Kit (Illumina), according to
the manufacturer’s instructions. To evaluate fragment average
and quantify libraries, Agilent 2100 Bioanalyzer, High Sensitivity
DNA kit (Agilent Technologies), and a qPCR-based KAPA library
quantification kit (KAPA Biosystems) were employed. Libraries
were pooled into 20 pM final concentration and submitted to the
sequencing reaction using the MiSeq Reagent kit (Illumina) and
the MiSeq Sequencing System (Illumina). Reads were trimmed
to remove low quality base at the ends and assembled using the
CLC Genomics Workbench platform (Qiagen). The total gene hit
counts and reads per kilobase million (RPKM) were calculated
using the same platform. Gene expression data were compared
between groups using the DESeq2 algorithm (Love et al., 2014).
Statistical Analysis
Experimental treatments were compared pairwise with control
treatments using two-way ANOVA, followed by Dunnett’s
multiple comparison test of Student’s t test with significance value
at p< 0.05.
RESULTS
Different Strains of ZIKV Productively
Infect BMEC
We hypothesized that ZIKV, as other neuropathogenic viruses,
invades the CNS by disrupting the BBB. Therefore, our first
approach was to verify the infectivity of different strains of ZIKV
in BMECs, the main component of the BBB. Primary human
BMECs were cultured on 6-well plates, and when 80% confluency
was reached, cells were infected with ZIKV-H, ZIKV-PR, ZIKV-
U at MOI of 0.01, in quadruplicates, or exposed to media only
(mock-infected control). The inoculum was left in contact with
the cells for 2 h to allow viral adsorption, carefully washed with
PBS, and then replaced with fresh uninfected media. Cell culture
supernatants and cell lysates were collected at 2, 4, and 6 dpi, and
submitted to RNA extraction. ZIKV levels were assessed by RT-
qPCR in cell culture supernatants and BMEC lysates (Figure 1A,
left and right panels, respectively). At 2 dpi, 108 ZIKV RNA
copies/mL were detected in both supernatants and cell lysates.
The viral burden reached a peak at 4 dpi (approximately 1010
ZIKV RNA copies/mL in the supernatants and cell lysates), and
at 6 dpi viral load decreased to the levels found at 2 dpi, the
effect that was accompanied by cell detachment as assessed by
microscopy, suggesting loss of cell viability (data not shown).
Productive infection was also assessed by expression of
viral proteins. ZIKV-infected BMEC lysates were submitted to
immunoblotting for NS-1 ZIKV protein (Figure 1B). NS-1 was
detected as early as 1 (data not shown) and 2 dpi in ZIKV-U-
infected BMEC. At 4 and 6 dpi, NS-1 expression was observed in
ZIKV-PR and ZIKV-U-infected cells; however, no NS-1 protein
was detected in ZIKV-H-infected cells (Figure 1B). On the other
hand, ZIKV infection of BMECs by immunofluorescence was
detected in cultures exposed to all ZIKV strains employed in
this study. In these experiments, BMECs were seeded on 8-well
chamber slides, infected at 80% confluency and MOI 0.01, and
stained for ZIKV NS1 protein (red) and DAPI (blue) at 2 dpi
(Figure 1C, arrows).
We next demonstrated that BMECs are not only permissive to
productive ZIKV infection, but these cells also produce infectious
viral particles. Supernatants from ZIKV-H-infected BMECs were
collected at 2 dpi and used to infect naïve Vero cells. Infection was
detected by a plaque assay using an agarose overlay and crystal
violet staining (Figure 1D).
Impact of ZIKV Infection on Endothelial
Permeability and TJ Protein Expression
in vitro
To evaluate the impact of ZIKV infection on endothelial
permeability, human primary BMECs were grown to confluence
on transwell inserts. Preliminary permeability experiments (data
not shown) were performed with BMECs infected with ZIKV-
H at MOI 0.01 and 1; however, no alteration of BMEC barrier
integrity was detected; therefore, the subsequent experiments
were performed at MOI 10 to ensure that all cultured cells were
infected. Control cultures were exposed to medium only. Then,
media in the apical compartment of the transwell system was
replaced with medium containing fluorescently tagged dextran
of either 20 kDa or 10 kDa (Figure 2A, upper and lower panels,
respectively). After 90-min incubation, fluorescence intensity
in the basal compartment was detected using a plate reader.
Infection with all ZIKV strains employed in the current study did
not induce significant differences in endothelial permeability.
Intriguingly, ZIKV infection caused alterations of the levels
of TJ proteins. Cells were infected with ZIKV-H, ZIKV-PR,
ZIKV-U, or mock-infected (media only) at MOI 0.01 and
lysed in RIPA buffer at 2, 4, and 6 dpi (Figure 2B). The
expression levels of ZO-1, occludin, and claudin-5, three major
TJ proteins involved in maintaining endothelial permeability,
were analyzed by immunoblotting. A significant reduction in
claudin-5 levels was observed in cells infected with ZIKV-PR
and ZIKV-U throughout the infection time points analyzed. In
addition, a significant downregulation of claudin-5 in ZIKV-H-
infected cells compared to mock-infected controls was observed
at 4 dpi and sustained at 6 dpi. On the other hand, ZIKV-
H-infected cells presented significantly increased expression of
ZO-1 at 2, 4, and 6 dpi. Interestingly, at 2 dpi, expression
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FIGURE 1 | Different strains of ZIKV productively infect brain microvascular endothelial cells (BMECs). Primary human BMECs were infected with different strains of
ZIKV: Honduras (ZIKV-H), Puerto Rico (ZIKV-PR), and Uganda (ZIKV-U) at MOI 0.01 for 2, 4, and 6 days. Mock-infected controls (Mock) were treated with virus-free
media. (A) ZIKV quantification by RT-qPCR, expressed as ZIKV RNA copies per mL in cell culture supernatant (left graph) and cell culture lysates (right graph).
(B) Detection of ZIKV NS-1 protein expression by immunoblotting in BMEC culture lysates. (C) Confocal images of ZIKV-infected BMECs stained for ZIKV NS-1
protein (red; arrows). Cell nuclei were stained with Hoechst (blue). Images are representative of three individual experiments (n = 6). (D) Representative image of the
plaque assay in Vero cells inoculated with BMEC culture supernatant at 2 dpi, showing infectivity of viral particles produced by infected BMECs. Dpi: days
post-infection.
of ZO-1 and occludin was significantly decreased in ZIKV-PR
and ZIKV-U-infected cells, compared to mock-infected controls.
Downregulation of occludin persisted at 4 and 6 dpi in ZIKV-PR-
infected cells (Figure 2B).
ZIKV Infection of Immunocompetent
Mice
Following the in vitro analyses, we next evaluated the impact of
ZIKV infection on BBB permeability and TJ protein expression
in vivo. In order to assess the kinetics of ZIKV infection,
immunocompetent C57BL/6J male mice were infected with 107
PFU of ZIKV-PR or vehicle and euthanized at 1 dpi (n = 4),
2 dpi (n = 4), 4 dpi (n = 4), 6 dpi (n = 4), and 8 dpi (n = 4).
Systemic infection was verified by the presence of ZIKV RNA in
spleen tissue homogenates and plasma samples by ZIKV-specific
RT-qPCR. In brain tissue homogenates, ZIKV RNA levels peaked
at 2 dpi (Figure 3). Therefore, all remaining animal experiments
were performed at this time point.
A total of 8 animals (4 males and 4 females) per group
(groups: ZIKV-H, ZIKV-PR, ZIKV-U, vehicle) were infected
intravenously with 107 PFU of ZIKV and euthanized at 2 dpi.
Plasma, spleen and brain tissues were collected and processed
for RNA extraction, followed by ZIKV detection by RT-qPCR.
Figure 4 depicts the RNA quantification for each tissue analyzed
and for individual ZIKV strains. No differences were observed
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FIGURE 2 | ZIKV infection impact on endothelial cell permeability and tight junction protein expression. (A) Using a transwell system, primary human brain
microvascular endothelial cells (BMECs) were infected with different strains of ZIKV: Honduras (ZIKV-H), Puerto Rico (ZIKV-PR), and Uganda (ZIKV-U) at MOI 10.
Mock-infected controls (Mock) were treated with virus-free media. At 2 dpi, culture media in the apical compartment of the transwell system was replaced with
medium containing fluorescently tagged dextran (FD) of 20 kDa (upper panel) and 10 kDa (lower panel). Basolateral levels of FD were assayed 90 min post-addition
of FD-dextran. Data are mean ± SEM, expressed as fold increase over mock-infected control; three independent experiments, each with n = 6. (B) Expression of
ZO-1, occludin, and claudin-5 was assessed by immunoblotting at 2, 4, and 6 dpi in primary human BMECs infected with ZIKV-H (blue), ZIKV-PR (red), and ZIKV-U
(green) at MOI 0.01. Mock-infected controls (Mock; black) were treated with virus-free media. Presented blots are cropped from the originals. Data are mean ± SEM
expressed as fold increase over mock-infected control. ∗p < 0.05 vs. mock-infected.
FIGURE 3 | ZIKV infection kinetics in immunocompetent mice. C57BL/6J
mice were infected intravenously with 107 PFU of ZIKV-PR or vehicle and
euthanized at 1 dpi (n = 4), 2 dpi (n = 4), 4 dpi (n = 4), 6 dpi (n = 4), and 8 dpi
(n = 4). ZIKV RNA quantification was assessed in plasma (in red; expressed as
RNA copies/mL of blood), spleen (in blue; expressed as RNA copies/106 cells)
and brain homogenates (in black; expressed as RNA copies/106 cells) by
qPCR. Data are mean ± SEM.
between male and female genders. Therefore, the results from
male and female mice were combined.
Zika virus RNA levels in plasma samples ranged from
6.5 × 103 to 1.2 × 105 copies/mL in ZIKV-H-infected animals,
from 8.3 × 103 to 0.8 × 105 copies/mL in ZIKV-PR-infected
animals, and from 0.3 × 103 to 3.7 × 105 copies/mL in ZIKV-
U-infected animals (Figure 4A). One female mouse infected with
ZIKV-U had undetectable levels of ZIKV RNA in the plasma, and
this animal was excluded from further analyzes.
Spleen levels of ZIKV RNA were the highest compared to
the other tissues analyzed (Figure 4B), with the mean value
2.8× 106 copies/106 cells for ZIKV-H-infected animals, 2.5× 106
copies/106 cells for ZIKV-PR-infected animals, and 1.3 × 106
copies/106 cells for ZIKV-U-infected animals.
Brain infection was detected in 3 out of 6 mice infected with
ZIKV-H or with ZIKV-PR, and in 5 out of 6 mice infected with
ZIKV-U. Mean levels of ZIKV RNA showed tendency to be
slightly lower in ZIKV-H-infected animals (2.8 × 102 copies/106
cells) compared to ZIKV-PR (1.6 × 104 copies/106 cells) and
ZIKV-U (1.5 × 103 copies/106 cells); however, the differences
were not significant (Figure 4C) (ANOVA; F = 1.537; p = 0.2268).
These data suggest that immunocompetent mice are a feasible
model to study ZIKV infection, including neuroinfection.
Brain Infection by ZIKV-H Correlates
With BBB Disruption
Our next series of experiments focused on the impact of
ZIKV infection on BBB permeability as assessed by the NaF
extravasation assay. The same animals that were used to
evaluate ZIKV-induced brain infection in Figure 3 were injected
intraperitoneally with 10% NaF, the dye was allowed to circulate
for 20 min, and NaF extravasation into the brain parenchyma
was measured as previously established in our laboratory (Park
et al., 2013). Infection with ZIKV-H induced significant increase
in the mean levels of NaF fluorescence in the brain, compared
to mock-infected controls (Figure 5). While the mean levels of
NaF fluorescence in the brains of ZIKV-PR and ZIKV-U-infected
animals were approximately 2-fold higher compared to mock-
infected controls, no statistical significance was detected due to
high in-group variability (Figure 5).
Results presented in Figure 3 indicated that 11/24 (45.8%)
mice subjected to ZIKV infection developed brain infection
and/or disruption of the BBB. Because ZIKV may infect the
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FIGURE 4 | Different strains of ZIKV infect immunocompetent mice. C57BL/6J mice were infected intravenously with 107 PFU of ZIKV-H, ZIKV-PR, and ZIKV-U, and
euthanized after 48 h. Mock-infected controls were injected intravenously with PBS. ZIKV RNA quantification was assessed in plasma (A; expressed as RNA
copies/mL of blood), spleen (B; expressed as RNA copies/106 cells) and brain homogenates (C; expressed as RNA copies/106 cells) by qPCR. Viral copy numbers
less than 101 were considered undetectable and were plotted as equal to zero. ZIKV RNA was detected for all animals in plasma and spleen homogenates (n = 8 per
group). Brain homogenates were positive for ZIKV RNA in 3/8, 3/8, and 5/8 animals infected with ZIKV-H, ZIKV-PR, and ZIKV-U, respectively. Data are mean ± SEM.
FIGURE 5 | Impact of ZIKV infection in BBB permeability in vivo. C57BL/6J
mice were infected intravenously with 107 PFU of ZIKV-H, ZIKV-PR, and
ZIKV-U, and euthanized after 48 h. Mock-infected controls were injected
intravenously with PBS. Approximately 20 min before euthanasia, animals
were treated intraperitoneally with 10% sodium fluorescein (NaF, 376 Da).
Translocation of NaF from plasma into the brain parenchyma was used as the
indicator of BBB integrity. Closed symbols indicate animals with ZIKV-infected
brains; open symbols indicate animals with no brain infection. Data are
mean ± SEM, expressed as fold change compared to mock-infected control,
n = 8 per group. ∗p = 0.0078, vs. mock-infected control.
brain as the result of penetration via the BBB, we attempted
to analyze if these changes are associated. Indeed, alterations
of BBB permeability were detected in all mice that developed
brain infection with ZIKV-H (Figure 5). However, ZIKV-PR
and ZIKV-U-infected mice presented a less evident association,
suggesting strain-specific effects for ZIKV-H infection.
Impact of ZIKV Infection on the
Expression of TJ Proteins in vivo
Using the microvessels isolated from the brains of mice analyzed
in Figures 3, 4, we evaluated the levels of claudin-5, occludin,
and ZO-1 by immunoblotting. Mice were grouped according
to the detection of ZIKV RNA in their brain, and the analyses
were performed separately on infected and mock-infected brains
at 2 dpi (Figure 6). Animals infected with ZIKV-H exhibited a
trend toward increased levels of TJ proteins in both infected and
mock-infected brains as compared to mock-infected controls.
ZIKV-PR-infected mice presented a trend toward decreased TJ
protein levels in the infected brains, but not in the mock-infected
brains. A similar trend in decreased TJ protein expression was
observed in ZIKV-U infected brains, with claudin-5 expression
reaching statistically significant values (Figure 6).
Impact of ZIKV Infection on
Transcriptome of Brain Microvessels
Our studies on the impact of ZIKV infection on brain
microvasculature and the BBB were completed by evaluating the
transcriptome profile of brain microvessels by high-throughput
RNA sequencing. Eight animals (4 males and 4 females) per
group were infected with ZIKV-H, ZIKV-PR, and ZIKV-U for
48 h. Mock-infected animals were included as negative controls.
As illustrated in Figure 3, ZIKV titers in the brain show biphasic
response, with the first peak at 2 dpi, followed by the second
peak at 7 dpi. Protein expression profiles and the transcriptome
analysis were performed during the first peak, i.e., at 2 dpi.
Whole brain tissue samples were homogenized and microvessels
were isolated and submitted to RNA extraction, followed by
sequencing, as described in section “Materials and Methods”.
Figure 7 illustrates differentially expressed genes bi-clustering
heat map of the top 30 genes sorted by adjusted p-values, between
mock-infected and ZIKV-infected animals. In addition, Table 1
depicts the top 30 upregulated (in blue) and downregulated
(in red) genes according to ZIKV strain and compared to
mock-infected controls. Samples are grouped according to the
similarities in gene expression.
The transcriptome of brain microvessels (Table 1) from
animals infected with ZIKV-H, ZIKV-PR, and ZIKV-U was
quite uniform, except for the Xist gene that was downregulated
in male animals, compared to females (p = 2.4 × 10−26).
The Xist gene ensures X-chromosome inactivation in female
placental mammals, and therefore its expression is expected
to be low in male animals. Gene expression related to BBB
function was not significantly changed in microvessels isolated
from ZIKV-infected animals as compared to mock-infected
controls. However, the analysis revealed upregulation of genes
involved in immune responses against viral infection, such as
Ddx60 (p = 1.2 × 10−24), Dhx58 (p = 8.8 × 10−45) and
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FIGURE 6 | ZIKV infection impact on tight junction proteins expression in vivo. Brain microvessels were isolated post-mortem from ZIKV-infected immunocompetent
mice at 2 dpi. Expression of ZO-1, occludin, and claudin-5 were assessed by immunoblotting in mock-infected and ZIKV-H (A), ZIKV-PR (B), and ZIKV-U (C)
infected animals. ZIKV-infected animals were divided according to viral detection in the brain, according to RT-qPCR data (Figure 4) (Brain negative: ZIKV-infected
mice with brain RT-qPCR negative; Brain positive: ZIKV-infected mice with brain RT-qPCR positive). GAPDH was used as an internal control. Presented blots are
cropped from the originals. Data are mean ± SEM expressed as fold increase over mock-infected control. ∗p < 0.05 vs. not infected (ANOVA + Dunnett).
Nlrc5 (p = 5.4 × 10−45). In addition, IFN-related immune
response genes, such as Zbp1 (p = 6.8 × 10−44) and genes of
the Oas (Oasl2, p = 8.1 × 10−72; Oas1b, p = 5.9 × 10−59;
Oas3, p = 5.3 × 10−13; Oas1g, p = 3.0 × 10−34; OasL1,
p = 1.7× 10−25; Oas2, p = 1.0× 10−59; Oas1a, p = 9.3× 10−38),
H2-Q (H2-Q4, p = 3.5 × 10−53; H2-Q5, p = 4.1 × 10−30;
H2-Q6, p = 5.2 × 10−55; H2-Q7, p = 1.6 × 10−54), Irf (Irf7,
p = 9.8 × 10−86; Irf9, p = 1.0 × 10−33), and Stat (Stat1,
p = 1.1× 10−46; Stat2, p = 5.9× 10−75) families were upregulated
in microvessels of ZIKV-infected animals. Interestingly, the gene
Rnf213 was significantly upregulated in ZIKV-infected animals
(p = 3.9 × 10−46). Rnf213 encodes a type Zn-finger protein
involved in mediating protein-protein interactions and has been
reported as a susceptibility gene for Moyamoya disease, a vascular
disorder of intracranial arteries (Liao et al., 2017). In addition,
expression of the gene encoding the cellular glycoprotein galectin
3 binding protein (Lgals3bp) was significantly upregulated in
ZIKV-infected animals, compared to mock-infected animals
(p = 3.0 × 10−28). The expression of Lgals3bp is upregulated
in the context of HIV-1 and HCV infections, and its expression
is associated with upregulation of IL-2, IL-6, granulocyte-
macrophage colony-stimulating factor (GM-CSF), and TNF-α,
contributing to an antiviral state (Lodermeyer et al., 2018).
Regarding the mostly downregulated genes, ribosomal protein
encoding genes were significantly downregulated in ZIKV-
infected animals, compared to mock-infected animals (Rpl3,
p = 4.1× 10−19; Rpl19, p = 1.7× 10−12; Rpl27a, p = 1.7× 10−19;
Rpl37a, p = 5.3 × 10−22; Rps10, p = 1.2 × 10−10; Rps14,
p = 4.8× 10−12; Rps27rt, p = 7.5× 10−7; Rps28, p = 3.1× 10−20).
Interestingly, one gene related to neurogenesis signaling
pathway and one gene related to cell differentiation signaling
pathway (Omp and Plekhb1, respectively) were significantly
downregulated in ZIKV-infected animals, as compared to mock-
infected animals (p = 0.0005 and p = 9.5× 10−23, respectively).
DISCUSSION
The present study aimed to identify the mechanisms by which
ZIKV crosses the BBB to infect CNS cells, a condition that
has been linked to microcephaly in infants and Guillain-
Barré syndrome in adults. Here we used an animal model
of ZIKV infection of immunocompetent adult mice to verify
possible damages in BBB integrity in the adult population.
We chose to analyze different strains of ZIKV in order to
verify possible differences in neurovirulence, and therefore in
neuropathogenesis.
The viral strains responsible for the recent outbreaks in the
Americas, leading to an alarmingly high number of cases of
microcephaly, were phylogenetically clustered to Asian strains of
ZIKV, previously associated with Guillain-Barré syndrome and
microcephaly (Lessler et al., 2016). In Asia, on the other hand,
the outbreaks emerged during the 2000 decade, as a consequent
spread of the ZIKV burden from Africa (Duffy et al., 2009).
African strains of ZIKV have not been associated with human
neuropathogenesis and the disease remains predominantly in
the sylvatic cycle (Lessler et al., 2016). Therefore, we analyzed
the impact of three different strains of ZIKV in BBB integrity:
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FIGURE 7 | Transcriptome of ZIKV-infected mice. Differentially expressed genes bi-clustering heat map of the top 30 genes sorted by adjusted p-values, between
mock-infected and ZIKV-infected animals. n = 8, per group.
the Honduras and Puerto Rico strains, representing the Asian
lineage; and the Uganda strain representing the African lineage.
Our data show that ZIKV infects and replicates in BMECs,
the main component of the BBB, independent of viral strain.
Moreover, we found no differences in infection and replication
efficiency among different strains in these cells, as shown by ZIKV
RNA quantification from both cell culture supernatants and cell
lysates (Figure 1A). In general, these results are in accordance
with previous reports showing that different strains of ZIKV, both
of the African and Asian lineages, productively infect and spread
in primary (Mladinich et al., 2017; Papa et al., 2017) and cell line
cultures of BMECs (Bramley et al., 2017). In contrast, the Asian
strains of ZIKV were demonstrated to have faster replication
kinetics in human umbilical vein endothelial cells compared to
African strains (Liu et al., 2016).
Next, we sought to determine if in vitro infection of BMEC was
accompanied by alterations in endothelial permeability. In vitro
endothelial integrity studies were performed using between 103
or 106 copies of ZIKV at MOI 0.01 or 10, respectively. In
addition, 107 PFU of ZIKV were employed for in vivo BBB
permeability assays. We did not observe any disruption of the
endothelial barrier function as determined by FITC-dextran
flux after ZIKV-U, ZIKV-PR, or ZIKV-H infection, even at
MOI of 10 (Figure 2A). Nevertheless, we did not perform
Electronic Cell-Substrate Impedance Sensing (ECIS) studies that
allow real-time measurements of TEER for detection of short-
lived permeability changes. In addition, permeability assessments
were performed only at 2 dpi, when the changes in TJ protein
expression were the most pronounced but were not continued
at later stages of infection. These factors constitute limiting
aspects of our in vitro ZIKV model. Similar lack of endothelial
permeability changes was reported for the ZIKV-U and a ZIKV
strain from Brazil (PE243) (Papa et al., 2017). These strains
also productively infected primary human BMECs but without
enhancing endothelial permeability. One caveat of that report was
that endothelial permeability was assessed by the translocation
of FITC-tagged BSA (Papa et al., 2017), i.e., a method suitable
to detect only very substantial permeability changes. In our
study, we used different molecular weight FITC-tagged dextran
molecules (10 kDa and 20 kDa) that were smaller than BSA
(67 kDa). Thus, our assay was more sensitive, strengthening
the conclusion that ZIKV is able to reach the CNS without
disrupting the BBB. Instead, invasion of the CNS by ZIKV might
be associated with endothelial transcytosis (Papa et al., 2017).
Infections of BMECs with other neurotropic flaviviruses,
such as tick-borne encephalitis virus (Palus et al., 2017) and
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TABLE 1 | Mouse brain microvessel transcriptome.
ZIKV-H ZIKV-PR ZIKV-U
Gene Fold change Adj. p-value Gene Fold change Adj. p-value Gene Fold change Adj.p-value
Ifi213 6.5 4.7E-14 Ppp2r2cos 5.8 1.2E-12 Eif2s3y 5.5 1.5E-04
Uty 5.9 1.6E-03 Gm29650 5.5 3.8E-03 Uty 5.4 1.6E-03
Ifit1 5.8 1.1E-26 Kdm5d 5.4 2.8E-04 Kdm5d 4.8 9.6E-03
Ddx60 5.7 1.6E-47 Uty 5.0 1.6E-03 Ddx3y 4.6 2.3E-03
Ddx3y 5.6 7.4E-05 Ddx3y 4.7 3.0E-05 Gm14429 4.2 9.8E-16
Gbp6 5.5 3.5E-10 Eif2s3y 4.5 1.1E-02 Gm42943 4.2 4.0E-11
Eif2s3y 5.4 1.1E-02 H2-Q6 4.4 2.0E-44 Ifit1 4.1 6.4E-23
Phf11d 5.4 5.2E-18 Zbp1 4.4 4.1E-36 Irf7 4.1 3.0E-233
Ifi44 5.3 6.2E-65 Irf7 4.3 9.2E-56 Ddx60 3.9 2.2E-51
Kdm5d 5.0 9.9E-03 H2-Q5 4.2 2.6E-32 Oas1b 3.9 6.6E-78
Ifi209 5.0 1.3E-07 H2-Q7 4.2 5.1E-45 Zbp1 3.8 2.2E-42
Gm43196 4.8 1.1E-11 Phf11d 4.1 7.4E-12 H2-Q6 3.8 3.9E-87
Mx1 4.8 1.3E-35 Oasl2 4.1 6.4E-45 Oasl2 3.8 2.7E-93
Ifi204 4.7 1.1E-11 Gm42943 4.1 6.1E-12 Oas3 3.7 5.8E-13
Zbp1 4.7 3.3E-66 Oas3 4.0 1.0E-12 H2-Q7 3.7 1.5E-99
Mx2 4.6 7.0E-65 Gm13833 4.0 2.9E-15 H2-Q5 3.4 4.5E-30
Trim30b 4.5 2.2E-09 9330175E14Rik 4.0 5.2E-12 Gm14411 3.4 2.4E-12
Gbp3 4.5 9.5E-13 Gm14429 3.9 2.2E-14 Gm28177 3.4 5.1E-25
Ifit3 4.3 2.5E-40 Gm16105 3.8 2.6E-31 Mx1 3.4 1.5E-24
Oasl2 4.3 8.9E-156 Oas1b 3.8 9.3E-32 Mx2 3.3 3.7E-79
Oas1b 4.2 4.4E-97 Nlrc5 3.8 9.7E-47 Oas1g 3.3 5.3E-32
Ifi27l2a 4.2 3.5E-66 Ddx60 3.7 2.2E-30 Ifi27l2a 3.3 1.5E-44
Phf11b 4.1 1.9E-09 Mx2 3.7 2.7E-38 Gm44802 3.2 1.1E-13
9330175E14Rik 4.1 2.2E-14 Mx1 3.6 6.5E-23 Nlrc5 3.2 1.3E-46
Tgtp2 4.1 8.4E-08 Gbp3 3.6 8.1E-27 Bst2 3.1 1.0E-200
Oas1g 4.1 2.7E-50 Oasl1 3.6 6.1E-26 Gm15813 3.1 1.7E-09
H2-Q6 3.9 5.8E-49 Ifi27l2a 3.6 6.5E-28 Oas2 3.1 4.1E-59
Trim30a 3.9 4.6E-36 Ifit1 3.6 2.8E-31 Gbp3 3.1 5.4E-16
Bst2 3.9 1.0E-122 Oas1g 3.6 2.2E-25 Ifi44 3.0 2.9E-20
Ifit3b 3.9 6.7E-22 4921534H16Rik 3.5 7.7E-11 Gm26869 3.0 1.8E-21
Rps15-ps2 −1.8 2.7E-04 Gm43018 −2.5 6.3E-19 Gm10736 −1.9 1.4E-15
Map3k10 −1.8 1.4E-13 Gm12987 −2.5 2.0E-09 Mgl2 −1.9 4.3E-10
Gp9 −1.8 6.4E-07 mt-Ta −2.6 2.5E-46 Gm22739 −1.9 8.0E-03
Git1 −1.8 6.7E-13 Gm37165 −2.6 1.8E-14 Gm47271 −1.9 1.5E-12
Fth1 −1.8 2.5E-28 Rps11-ps1 −2.6 2.5E-31 Gm4149 −1.9 1.5E-11
Kcnab2 −1.8 5.9E-14 Gm26638 −2.6 1.8E-20 Rpl37a −1.9 1.6E-24
Ttbk1 −1.9 6.8E-19 Gm15700 −2.6 3.0E-09 mt-Ta −1.9 1.7E-15
Ddn −1.9 1.7E-21 2810432F15Rik −2.6 9.0E-15 Tsix −1.9 1.6E-04
Brsk1 −1.9 3.2E-18 Gm42443 −2.6 3.3E-17 Gm12987 −1.9 4.1E-07
mt-Tq −1.9 6.8E-10 2900002M20Rik −2.7 6.9E-16 Rps27rt −1.9 9.0E-10
Scrt1 −1.9 6.1E-16 Gm17981 −2.7 1.2E-23 Gm10123 −2.0 3.8E-22
Gkn3 −2.0 6.3E-12 Gm23127 −2.7 5.7E-13 Gm24336 −2.0 7.5E-09
Ccdc85c −2.0 1.6E-14 Gm38083 −2.7 4.3E-15 Rpl3-ps1 −2.0 2.2E-15
Neurl1a −2.0 5.1E-15 Gm24927 −2.8 9.0E-17 Omp −2.0 2.0E-02
Mgl2 −2.0 1.6E-10 Gm26692 −2.8 4.1E-11 Gm6204 −2.0 1.0E-08
Alas2 −2.0 8.7E-11 4930528J11Rik −2.8 2.9E-09 Gm17409 −2.0 9.2E-09
Dlgap3 −2.0 6.0E-18 Gm24492 −2.9 1.2E-13 Rpl10a-ps1 −2.1 3.6E-13
Mbp −2.0 1.5E-26 Gm47271 −2.9 4.6E-22 Rps10-ps1 −2.1 1.5E-09
Tmcc2 −2.1 6.1E-17 Gm24406 −2.9 4.9E-16 Gm7536 −2.1 6.4E-11
Plekhb1 −2.1 2.3E-29 Gm37436 −2.9 2.2E-09 Rps28 −2.2 4.5E-22
(Continued)
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TABLE 1 | Continued
ZIKV-H ZIKV-PR ZIKV-U
Gene Fold change Adj. p-value Gene Fold change Adj. p-value Gene Fold change Adj.p-value
Ppp1r9b −2.2 1.7E-18 Gm43884 −3.0 4.6E-07 Alas2 −2.2 1.2E-29
Rasl10b −2.2 4.0E-16 Hba-a1 −3.1 3.7E-07 Gm5805 −2.2 1.4E-12
Gm6204 −2.2 5.2E-08 Tsix −3.1 2.6E-11 Slc4a1 −2.3 1.2E-07
Phospho1 −2.3 4.1E-10 Hba-a2 −3.1 7.0E-07 Gm15700 −2.3 7.5E-08
Omp −2.3 9.5E-03 Gm22739 −3.1 2.0E-05 Mageb16-ps1 −2.8 9.8E-15
Hbb-bs −2.8 4.1E-13 Gm37211 −3.2 4.8E-27 Hba-a1 −3.8 2.1E-50
Hba-a1 −2.8 2.2E-12 Gm26129 −3.3 1.4E-11 Hba-a2 −3.8 2.6E-52
Hba-a2 −2.8 2.4E-14 Mageb16-ps1 −3.5 4.2E-05 Xist −4.3 4.7E-05
Xist −3.8 8.0E-04 Gm17409 −3.9 3.7E-16 Hbb-bs −4.5 6.2E-89
Hbb-bt −3.9 3.0E-13 Xist −4.4 4.3E-05 Hbb-bt −5.2 7.3E-56
The top 30 upregulated (in blue) and downregulated (in red) genes according to ZIKV strain and compared to mock-infected controls.
West Nile virus (Roe et al., 2012) were also reported as not
resulting in disruption of endothelial barrier function. On the
other hand, WNV-induced alterations of the BBB in vivo were
shown to be transient and regulated by the interaction of the
host with viral factors, such as pathogen-associated molecular
patterns (PAMPs; e.g., viral RNA) (Daniels et al., 2014; Cain
et al., 2017). Recently, Puerta-Guardo et al. (2019) described
in vitro endothelial cell permeability alterations induced by NS1
proteins of different flaviviruses, including ZIKV. Our in vivo
studies revealed that significant changes in BBB permeability for
NaF (molecular weight 376 Da) occurred only among animals
infected with the Honduras strain. In addition, a clear trend
between the presence of the neuroinfection and increased BBB
permeability was observed in mice infected with ZIKV-H but not
ZIKV-U or ZIKV-PR, indicating strain-specific effects (Figure 5).
The paradox between the in vitro and in vivo permeability
results may be explained by the limitations of measurements
of endothelial permeability with fluorescent dextran polymers.
Another possibility may be lack in our in vitro model other
components of neurovascular unit, such as astrocytic foot
processes and contributing microglial cells. Indeed, astrocytes
are a critical component of the BBB microenvironment, and
secreted products from activated microglial cells contribute to the
infectious process (Nau et al., 2014).
Interestingly, when we evaluated the expression of TJ
proteins after ZIKV infection, significant changes starting at
2 dpi, and at a physiologically relevant dose (MOI 0.01) were
observed (Figure 2B). Expression of claudin-5 and occludin
were significantly downregulated in ZIKV-PR and ZIKV-U
infected BMECs, whereas ZO-1 expression was upregulated.
Changes in TJ protein expression are frequently accompanied
by disruption of endothelial integrity, as demonstrated for other
neurotropic flaviviruses, such as Japanese encephalitis virus
(Kim et al., 2016) and dengue virus (Velandia-Romero et al.,
2016). However, the role of occludin in maintaining barrier
function is not clearly defined as occludin-deficient mice form
paracellular barriers and do not exhibit defects in epidermal,
respiratory, or bladder TJ functions (Saitou et al., 2000; Schulzke
et al., 2005). While downregulation of claudin-5 has been
very strongly associated with an increase in transendothelial
permeability (Nitta et al., 2003; Andras et al., 2005; Argaw et al.,
2009), it is possible that upregulation of ZO-1 can maintain
functional barrier properties by affecting other claudins or other
transmembrane TJ proteins.
The in vivo analyses of TJ protein expression in ZIKV-infected
brains agree with in vitro data. In ZIKV-H-infected animals, all TJ
proteins analyzed tended to be upregulated. In ZIKV-PR infected
animals, a tendency in the upregulation of ZO-1 and occludin
expression was evident in mock-infected brains; however, a
reverse trend was observed in infected brains. Regarding
infection with ZIKV-U stains, TJ proteins were downregulated in
infected brains, achieving statistical significance only for claudin-
5. Overall, the pattern of the observed changes suggests specific
responses from the BBB during neuroinfection by individual
strains of ZIKV. However, the kinetics of TJ alterations may
depend not only on different viral strains but be individually
tuned for individual TJ proteins. It also should be noted that
modulation of the BBB permeability is frequently regulated by
transient phosphorylation/dephosphorylation of TJ proteins and
not their overall expression levels (Siddiqui et al., 2015). Thus,
studies on transient changes in TJ phosphorylation status may
consist an important future direction of research on the BBB
involvement in ZIKV entry into the CNS.
After the recent Zika epidemic, the development of animal
models to study the virus pathogenesis has been a research
priority. There are approximately 20 mouse models of ZIKV
infection published in the literature (Morrison and Diamond,
2017); however, only a few studies were successful in using
immunocompetent adult mice (Larocca et al., 2016; Ma et al.,
2016; Yockey et al., 2016). Among these studies, ZIKV was
detected in blood (Larocca et al., 2016), testes (Ma et al., 2016),
and vaginal tissues (Yockey et al., 2016), correlating with the
inoculation route (intravenous, intratesticular, and intravaginal,
respectively). To our knowledge, our study is the first to
show an immunocompetent adult mouse model of systemic
and brain infection (Figure 4). Our model could serve as a
stepping stone for the development of more robust animal
models associated with ZIKV pathogenesis in adults, such as
Guillain-Barré syndrome (Morrison and Diamond, 2017). It is
well-established that ZIKV infects neural progenitor cells, mature
Frontiers in Microbiology | www.frontiersin.org 11 September 2019 | Volume 10 | Article 2158
fmicb-10-02158 September 16, 2019 Time: 16:33 # 12
Leda et al. Zika Virus and the Blood–Brain Barrier
neurons, astrocytes, and brain endothelial cells in the CNS. In
addition, it has been recently reported that ZIKV infection of
microglia cells leads to modulation of the expression of numerous
metabolites, such as phosphatidylcholine, phosphatidylserine,
ceramide and sphingomyelin, and carboxylic acids. Some of these
metabolites are involved in neuronal differentiation, regulation
of apoptosis, virion architecture, and viral replication. In the
same study, ZIKV infection was associated with concomitant
secretion of inflammatory mediators linked to CNS inflammation
and alterations in endothelial and microvascular permeability,
such as IL-6, TNF-α, IL-1β, iNOS, and NO. Furthermore, ZIKV
infection resulted in upregulation of the expression of the gene
encoding for CX3CR1, a chemokine receptor known to regulate
functional synapse plasticity and signaling between microglial
cells (Diop et al., 2018). Upregulation of these proinflammatory
mediators is important because inflammatory Th1 cytokines,
such as TNF-α, IL-1β, IL-6 and CCL-2 play important roles in
increasing endothelial/microvascular permeability, both in vivo
and in vitro (Toborek et al., 1995; Nguyen et al., 2003; Fahey
and Doyle, 2019). IFN-γ, on the other hand, tends to stabilize
TJs (Capaldo and Nusrat, 2009). Consistent with these results,
our analyses performed on microvessels isolated from ZIKV-
infected brains also revealed upregulation of genes involved
in immune responses against viral infection (Figure 7). In
addition, we observed downregulation of selected genes related
to neurogenesis and cell differentiation, namely, Omp and
Plekhb1. Intriguing further studies are needed to determine
if these gene alterations might influence the development
of neuronal division and growth, leading to microcephaly
in offspring. While the gene expression changes observed
in the present study were independent of the infection by
individual ZIKV strains, detailed genetic studies of different
strains may reveal viral genetic determinants affecting ZIKV-
mediated input on TJ and BBB functionality as well as on
CNS neuroinvasion.
By studying different strains of ZIKV, we aimed to determine
possible differences in viral tropism that lead to brain infection
and neuropathogenesis. We found no significant difference
between African and Asian strains regarding viral replication
kinetics, viral burden, and neurotropism, with approximately
40–50% of infected animals having detectable ZIKV RNA
in their brain tissue (Figure 4). These results highlight
the importance of studies on immunocompetent animals,
as experiments performed on immunocompromised animals
obtained conflicting results, associating African strains with
worse disease progression (Dowall et al., 2017; Simonin et al.,
2017; Tripathi et al., 2017).
In conclusion, our results indicate that ZIKV penetrates the
brain parenchyma early after infection resulting in brain infection
of approximately 40–50% of infected immunocompetent mice.
However, increased permeability of the BBB does not appear to be
the major mechanism for CNS entry of ZIKV, though changes in
TJ protein expression and strain-dependent disturbances in BBB
permeability were observed.
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